Stocks Sell Off on Troubling Trade Headlines

Larry Kudlow said there's a "sizable difference" between the U.S. and China on trade

by Patrick Martin

Published on Feb 7, 2019 at 12:04 PM

The Dow Jones Industrial Average (DJI) is sharply lower at midday. Global economic concerns initially sent the index down triple digits, and losses were exacerbated after White House economic advisor Larry Kudlow told Fox Business there is "sizable difference" between the U.S. and China on any sort of trade deal. Additionally, a CNBC report suggested a meeting between President Donald Trump and Chinese leader Xi Jinping is unlikely to happen ahead of a March 1 trade deadline. Elsewhere, investors are digesting a sharp drop in weekly jobless claims, while March-dated crude futures are down 3.2% at $52.24 per barrel. 

Continue reading for more on today's market, including:

  • Chipotle stock is surging after earnings.
  • This drug stock is down 65% today.
  • Plus, pre-earnings bulls try on Skechers; GRUB buried by earnings once again; and Cardinal Health climbs past a key trendline. 

Midday market Stats Feb 7

There's notable options activity surrounding Skechers USA Inc (NYSE:SKX) ahead of the shoe retailer's fourth-quarter earnings report, due after the close tonight. More than 5,400 calls have changed hands, four times the average intraday amount. The weekly 2/8 28-strike calls are the most popular, and it looks like new positions are being purchased. SKX is down 1% to trade at $27.40 today, but has already gained 21% in 2019.

GrubHub Inc (NYSE:GRUB) is one of the worst stocks on the New York Stock Exchange (NYSE) today, down 18.4% to trade at $68.48, though well off its earlier annual low of $66.62. The meal delivery company's fourth-quarter earnings and sales missed estimates, thanks to heavy competition from Amazon Restaurants and Uber Eats. GRUB is known for its volatile earnings history, and has now erased its gains from 2019. 

Cardinal Health Inc (NYSE:CAH) is up 6.9% to trade at $54.20, after the healthcare giant's fiscal second-quarter earnings beat expectations. The company cited increased strength from its pharma business as a catalyst for the upbeat report. CAH now boasts a 20% gain in 2019, and is set to close above its 200-day moving average for the first time since early December.

MMC Daily Chart CAH

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How American Lithium Tech May Be Poised for 614% Growth
A new lithium technology could change the face of lithium production forever.